Origin of late-onset autoimmune disease

Immunology and Allergy Clinics of North America

Volumn 23, Issue 1, 2003, Pages 65-82

  Hsu, Hui Chen ^a   Mountz, John D ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DISEASE ASSOCIATION; DISEASE COURSE; FIBROSING ALVEOLITIS; HASHIMOTO DISEASE; HUMAN; ONSET AGE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

AGE OF ONSET; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; T-LYMPHOCYTES;

EID: 0037331382     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(02)00074-7     Document Type: Review

References (86)

1. Mishra N, Kammer GM. Clinical expression of autoimmune diseases in older adults. Clin Geriatr Med 1998;14:515-42.
2. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 1998;840: 45-50.
3. Yamada H, Uchigata Y, Kawasaki E, et al. Onset age-dependent variations of three islet specific autoantibodies in Japanese IDDM patients. Diabetes Res Clin Pract 1998;39:211-7.
4. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999;26:653-7.
5. Yoshida H, Inoue T, Hakamata Y, et al. Slowly progressive IDDM with rheumatoid arthritis and Hashimoto disease in high elderly [in Japanese]. Nippon Ronen Igakkai Zasshi 1998;35:571-6.
6. Dalziel JA, Wilcock GK. Progressive systemic sclerosis in the elderly. Postgrad Med J 1979;55: 192-3.
7. de Troyer A, Yemault JC. Inspiratory muscle force in normal subjects and patients with interstitial lung disease. Thorax 1980;35:92-100.
8. Kyndt X, Launay D, Hebbar M, et al. Influence of age on the clinical and biological characteristics of systemic scleroderma [in French]. Revue de Mèdecine Interne 1999;20:1088-92.
9. Effros RB. Costimulatory mechanisms in the elderly. Vaccine 2000;18:1661-5.
10. Effros RB. Long-term immunological memory against viruses. Mech Ageing Dev 2000;121: 161-71.
11. Ku CC, Kappler J, Marrack P. The growth of the very large CD8+ T cell clones in older mice is controlled by cytokines. J Immunol 2001;166:2186-93.
12. Li F, Yarilin DA, Valiando J, et al. Tumor antigen drives a persistent oligoclonal expansion of CD8+ T cells in aged mice. Eur J Immunol 2002;32:1650-8.
13. Maini MK, Soares MV, Zilch CF, et al. Virus-induced CD8+ T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: a mechanism for rescue from replicative senescence. J Immunol 1999;162:4521-6.
14. Wack A, Cossarizza A, Heltai S, et al. Age-related modifications of the human αβ T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol 1998;10:1281-8.
15. Schwab R, Szabo P, Manavalan JS, et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997;158:4493-9.
16. Callahan JE, Kappler JW, Marrack P. Unexpected expansions of CD8-bearing cells in old mice. J Immunol 1993;151:6657-69.
17. Ku CC, Kotzin B, Kappler J, et al. CD8+ T-cell clones in old mice. Immunol Rev 1997;160: 139-44.
18. Posnett DN, Sinha R, Kabak S, et al. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994;179: 609-18.
19. Posnett DN, Edinger JW, Manavalan JS, et al. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones. Int Immunol 1999;11: 229-41.
20. McCarron M, Osborne Y, Story CJ, et al. Effect of age on lymphocyte proliferation. Mech Ageing Dev 1987;41:211-8.
21. Adibzadeh M, Mariani E, Bartoloni C, et al. Lifespans of T lymphocytes. Mech Ageing Dev 1996;91:145-54.
22. Adibzadeh M, Pohla H, Rehbein A, et al. Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech Ageing Dev 1995;83:171-83.
23. McLean AR, Michie CA. In vivo estimates of division and death rates of human T lymphocytes. Proc Natl Acad Sci U S A 1995;92:3707-11.
24. Akbar AN, Soares MV, Plunkett FJ, et al. Differential regulation of CD8+ T cell senescence in mice and men. Mech Ageing Dev 2000;121:69-76.
25. Plunkett FJ, Soares MV, Salmon M, et al. Regulation of apoptosis and replicative senescence in CD8+ T cell following acute viral infection. Apoptosis 2000;5:431-4.
26. Kabelitz D, Janssen O. Antigen-induced death of T-lymphocytes. Front Biosci 1997;2:D61-77.
27. Van Parijs L, Ibraghimov A, Abbas AK. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996;4:321-8.
28. van Parijs L, Perez VL, Abbas AK. Mechanisms of peripheral T cell tolerance. Novartis Found Symp 1998;215:5-20.
29. Zhang J, Bardos T, Mikecz K, et al. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis. J Immunol 2001;166:4981-6.
30. Zhang J, Gao JX, Salojin K, et al. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J Exp Med 2000;191:1017-30.
31. Zhou T, Edwards 3rd CK, Mountz JD. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 1995;182:129-37.
32. Hsu HC, Shi J, Yang P, et al. Activated CD8(+) T cells from aged mice exhibit decreased activation-induced cell death. Mech Ageing Dev 2001;122:1663-84.
33. Hsu HC, Zhou T, Shi J, et al. Aged mice exhibit in vivo defective peripheral clonal deletion of D(b)/H-Y reactive CD8(+) T cells. Mech Ageing Dev 2001;122:305-26.
34. Allen RD, Marshall JD, Roths JB, et al. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 1990;172:1367-75.
35. Roths JB, Murphy ED, Eicher EM. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med 1984;159:1-20.
36. Mountz JD, Zhou T, Eldridge J, et al. Transgenic rearranged T cell receptor gene inhibits lymphadenopathy and accumulation of CD4-CD8-B220+ T cells in lpr/lpr mice. J Exp Med 1990;172:1805-17.
37. Smathers PA, Santoro TJ, Chused TM, et al. Studies of lymphoproliferation in MRL-lpr/lpr mice. J Immunol 1984;133:1955-61.
38. Davidson WF, Holmes KL, Roths JB, et al. Immunologic abnormalities of mice bearing the gld mutation suggest a common pathway for murine nonmalignant lymphoproliferative disorders with autoimmunity. Proc Natl Acad Sci U S A 1985;82:1219-23.
39. Santoro TJ, Luger TA, Ravache ES, et al. In vitro correction of the interleukin 2 defect of autoimmune mice. Eur J Immunol 1983;13:601-4.
40. Santoro TJ, Malek TR, Rosenberg YJ, et al. Signals required for activation and growth of autoimmune T lymphocytes. J Mol Cell Immunol 1984;1:347-56.
41. Radvanyi LG, Raju K, Spaner D, et al. Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from aumimmune lpr mice. Cell Immunol 1998;183:1-12.
42. Haynes L, Linton PJ, Eaton SM, et al. Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 1999;190:1013-24.
43. Santiago-Raber ML, Lawson BR, Dummer W, et al. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol 2001;167:4067-74.
44. Salvador JM, Hollander MC, Nguyen AT, et al. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 2002;16:499-508.
45. Aggarwal S, Gollapudi S, Gupta S. Increased TNF-α-induced apoptosis in lymphocytes from aged humans: changes in TNF-α receptor expression and activation of caspases. J Immunol 1999;162:2154-61.
46. Dennett NS, Barcia RN, McLeod JD. Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells. Exp Gerontol 2002;37:271-83.
47. Gupta S. Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp Gerontol 2002;37:293-9.
48. Phelouzat MA, Arbogast A, Laforge T, et al. Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev 1996;88:25-38.
49. Phelouzat MA, Laforge T, Arbogast A, et al. Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mech Ageing Dev 1997;96:35-46.
50. Bryl E, Gazda M, Foerster J, et al. Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4. Blood 2001;98:1100-7.
51. Bryl E, Vallejo AN, Weyand CM, et al. Down-regulation of CD28 expression by TNF-α. J Immunol 2001;167:3231-8.
52. Spaulding C, Guo W, Effros RB. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds ofantigen-specific proliferation. Exp Gerontol 1999; 34:633-44.
53. Spaulding CC, Walford RL, Effros RB. The accumulation of non-replicative, non-functional, senescent T cells with age is avoided in calorically restricted mice by an enhancement of T cell apoptosis. Mech Ageing Dev 1997;93:25-33.
54. Hemdon FJ, Hsu HC, Mountz JD. Increased apoptosis of CD45RO-T cells with aging. Mech Ageing Dev 1997;94:123-34.
55. Ye P, Kirschner DE. Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J Immunol 2002;168:4968-79.
56. Grizzle WE, Mountz JD, Yang P, et al. BXD Recombinant inbred mice represents a novel T-cell mediated immune response tumor model. Int J Cancer 2002;29:2027-30.
57. Koetz K, Bryl E, Spickschen K, et al. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000;97:9203-8.
58. Po JL, Gardner EM, Anaraki F, et al. Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech Ageing Dev 2002;123:1167-81.
59. Meyer KC. The role of immunity in susceptibility to respiratory infection in the aging lung. Respir Physiol 2001;128:23-31.
60. Hsu HC, Zhang HG, Song GG, et al. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection. Arthritis Rheum 2001;44:2146-59.
61. Zhang HG, Liu D, Heike Y, et al. Induction of specific T-cell tolerance by adenovirus-transfected. Fas ligand-producing antigen presenting cells. Nat Biotechnol 1998;16: 1045-9.
62. Zhang HG, Su X, Liu D, et al. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J Immunol 1999;162:1423-30.
63. Fleck M, Kem ER, Zhou T, Podlech J, Wintersberger W, Edwards 3rd CK, et al. Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus. J Clin Invest 1998;102:1431-43.
64. Fleck M, Zhang HG, Kern ER, et al. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local FasL gene transfer. Arthritis Rheum 2001;44:964-73.
65. Zhang HG, Fleck M, Kem ER, et al. Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice. J Clin Invest 2000;105: 813-21.
66. Narayanan K, Rajendran CP, Porkodi R, et al. Late onset rheumatoid arthritis - a clinical and laboratory study. J Assoc Physicians India 2001;49:311-3.
67. Yudoh K, Matsuno H, Osada R, et al. Decreased cellular activity and replicative capacity of osteoblastic cells isolated from the periarticular bone of rheumatoid arthritis patients compared with osteoarthritis patients. Arthritis Rheum 2000;43:2178-88.
68. Freitas AA, Rocha B. Peripheral T cell survival. Curr Opin Immunol 1999;11:152-6.
69. Knox DL. Psoriasis and intraocular inflammation. Trans Am Ophthalmol Soc 1979;77:210-24.
70. Rantakokko K, Rimpilainen M, Uksila J, et al. Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 1997;15:399-404.
71. Punzi L, Pianon M, Rossini P, et al. Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis 1999;58:226-9.
72. Caplanne D, Tubach F, Le Parc JM. Late onset spondylarthropathy: clinical and biological comparison with early onset patients. Ann Rheum Dis 1997;56:176-9.
73. Mackall CL, Hakim FT, Gress RE. Restoration of T-cell homeostasis after T-cell depletion. Semin Immunol 1997;9:339-46.
74. Dummer W, Ernst B, LeRoy E, et al. Autologous regulation of naive T cell homeostasis within the T cell compartment. J Immunol 2001;166:2460-8.
75. Li XC, Demirci G, Ferrari-Lacraz S, et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 2001;7:114-8.
76. Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995;154:5093-102.
77. Tan JT, Ernst B, Kieper WC, et al. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002;195:1523-32.
78. Schluns KS, Kieper WC, Jameson SC, et al. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000;1:426-32.
79. Ku CC, Murakami M, Sakamoto A, et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000;288:675-8.
80. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000;191:771-80.
81. Formiga F, Moga I, Pac M, et al. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI: SLE Disease Activity Index. Lupus 1999;8:462-5.
82. Ho CT, Mok CC, Lau CS, et al. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998;57:437-40.
83. Mak SK, Lam EK, Wong AK. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus 1998;7:23-8.
84. Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 1994;21:1463-7.
85. Peltomaa R, Leirisalo-Repo M, Helve T, et al. Effect of age on 3 year outcome in early rheumatoid arthritis. J Rheumatol 2000;27:638-43.
86. Lopez-Montilla MD, Gonzalez J, Martinez FG, et al. Clinical features of late onset psoriatic arthritis. Exp Gerontol 2002;37:441-3.